Aldosterone and metabolic syndrome: is increased aldosterone in metabolic syndrome patients an additional risk factor?
about
Vascular disturbances in primary aldosteronism: clinical evidenceRenin-Angiotensin-aldosterone system in diabetes and hypertensionDisordered aldosterone-volume relationship in end-stage kidney disease.Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative reviewEpithelial Na+ channel (ENaC), hormones, and hypertension.Effect of low dose mineralocorticoid receptor antagonist eplerenone on glucose and lipid metabolism in healthy adult malesBlood pressure response to angiotensin II is enhanced in obese Zucker rats and is attributed to an aldosterone-dependent mechanism.Abnormal aldosterone physiology and cardiometabolic risk factors.Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum.Canonical transient receptor potential channels expression is elevated in a porcine model of metabolic syndromeRelationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea hypopnea syndrome: effect of continuous positive airway pressure treatment.Mineralocorticoid receptor blockade in chronic kidney disease.Mineralocorticoid receptor-associated hypertension and its organ damage: clinical relevance for resistant hypertension.Resistant hypertension in diabetes mellitus.The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy.Modified high-density lipoprotein modulates aldosterone release through scavenger receptors via extra cellular signal-regulated kinase and Janus kinase-dependent pathways.Very-low-density lipoprotein mediates transcriptional regulation of aldosterone synthase in human adrenocortical cells through multiple signaling pathways.The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism.Increased urinary aldosterone excretion is associated with subcutaneous not visceral, adipose tissue area in obese individuals: a possible manifestation of dysfunctional subcutaneous adipose tissue.Plasma adrenocorticotropic hormone but not aldosterone is correlated with blood pressure in patients with aldosterone-producing adenomas.Scoring system for the diagnosis of bilateral primary aldosteronism in the outpatient setting before adrenal venous sampling.Elevated mineralocorticoid receptor activity in aged rat vascular smooth muscle cells promotes a proinflammatory phenotype via extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase and epidermal growth factor receptor-dependent
P2860
Q26852612-2FB01311-34D2-4946-82DA-72B47BA5794FQ28308222-DD2299FF-6F42-4E48-BD37-8FF57EF54572Q33764028-62129661-E16F-4D73-BFCA-196C06C3BABDQ34018585-D1422A7F-8405-4FAA-A58B-5F89519178B5Q34025435-7F26AFC8-C287-4F21-8E89-103A7AB310FBQ35490517-7D2FB69F-3FD7-4BB6-8E4C-45F5015AD6A1Q36252804-47183728-AFED-4F42-8263-FF3992EE244FQ36737227-217B8068-E633-49F0-B079-1F37016775ADQ37126967-F829FF45-F040-466A-A96A-C947AC2AD54CQ37176258-898C1E39-56E6-4BA7-8D68-1A52909E3893Q37495691-C3D561BA-B97A-4935-9D92-737684D420D6Q37861583-6DB73C82-758B-4277-802F-2740AD006F4BQ37976974-87227E48-D195-4CDC-BB84-4DF9AEA8E656Q38223311-DDA1BE6D-6706-459F-8C18-A0D9665694DDQ38374536-A06C3E74-D720-42BD-A727-296A6CE01A52Q39387327-087C1FEE-C50C-4D83-A113-FE0004D6F900Q39397029-FD7D2B20-D8F3-4D09-80DE-9477C045BD98Q43007154-BA4685E5-9C59-4777-98CB-80CCA031B537Q43894263-15C48DBB-38CE-4BCD-AF17-47F13EA4E1B0Q47610724-23131F82-24CE-42E3-8FAB-72B2548285D0Q47618963-1B4479E1-074F-480A-9C6A-A23431A87AF3Q55216617-A76EC17B-C8E5-4ECE-B1A1-19C5593B7782
P2860
Aldosterone and metabolic syndrome: is increased aldosterone in metabolic syndrome patients an additional risk factor?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aldosterone and metabolic synd ...... nts an additional risk factor?
@en
Aldosterone and metabolic synd ...... nts an additional risk factor?
@nl
type
label
Aldosterone and metabolic synd ...... nts an additional risk factor?
@en
Aldosterone and metabolic synd ...... nts an additional risk factor?
@nl
prefLabel
Aldosterone and metabolic synd ...... nts an additional risk factor?
@en
Aldosterone and metabolic synd ...... nts an additional risk factor?
@nl
P1433
P1476
Aldosterone and metabolic synd ...... nts an additional risk factor?
@en
P2093
Alexander W Krug
Monika Ehrhart-Bornstein
P304
P356
10.1161/HYPERTENSIONAHA.107.109439
P407
P577
2008-03-17T00:00:00Z